Lianya Pharmaceutical announced that the company's initial public offering of shares and its GEM listing application has been reviewed and approved by the Shenzhen Stock Exchange Listing Committee and approved for registration by the China Securities Regulatory Commission. It is proposed to publicly issue 1337395.63 million shares, accounting for 15.00% of the total share capital after issuance, all of which are new public shares. The online and offline subscription date is September 28, 2026. There is no need to pay subscription funds at the time of purchase. The initial inquiry period is 9:30-15:00 on September 22, 2026.

Lianya Pharmaceutical announced that the company's initial public offering of shares and its GEM listing application has been reviewed and approved by the Shenzhen Stock Exchange Listing Committee and approved for registration by the China Securities Regulatory Commission. It is proposed to publicly issue 1337395.63 million shares, accounting for 15.00% of the total share capital after issuance, all of which are new public shares. The online and offline subscription date is September 28, 2026. There is no need to pay subscription funds at the time of purchase. The initial inquiry period is 9:30-15:00 on September 22, 2026.